Locomotor and Reinforcing Effects of Pentedrone, Pentylone and Methylone in Rats
Preprint
Abstract
The broad diversity of synthetic cathinone psychostimulant drugs that are available to users complicates research efforts to provide understanding of health risks. Second generation cathinones pentedrone and pentylone are distinguished from each other by the 3,4-methylenedioxy structural motif (which distinguishes methamphetamine from 3,4-methylenedioxymethamphetamine) and each incorporates the α-alkyl chain motif contained in the transporter-inhibitor cathinones (3,4-methylenedioxypyrovalerone (MDPV), α-pyrrolidinopentiophenone (α-PVP)) but not in the monoamine releasers (mephedrone, methylone). Studies were conducted in male and female Wistar rats to compare locomotor and thermoregulatory effects of pentedrone, pentylone and methylone using an implanted radiotelemetry system. Reinforcing effects were assessed in female Wistar rats trained in the intravenous self-administration (IVSA) procedure and subjected to dose-substitution (0.025-0.3 m/gkg/inf) under a fixed-ratio 1 response contingency. Pentedrone, pentylone and methylone dose-effect curves were contrasted with those for α-PVP and α-pyrrolidinohexiophenone (α-PHP). Dose dependent increases in locomotion were observed after intraperitoneal injection of pentylone (0.5-10.0 mg/kg), pentedrone (0.5-10.0 mg/kg) or mephedrone (0.5-10.0 mg/kg) in male and female rats. The maximum locomotor effect was similar across drugs but lasted longest after pentedrone. Mean body temperature did not vary systematically more than 0.5 °C after pentedrone or pentylone in either sex. A sustained hyperthermia (0.4-0.8 °C) was observed for four hours after 10 mg/kg methylone in male rats. More infusions of pentedrone or pentylone were self-administered compared with methylone, but all three were less potent than α-PVP or α-PHP. These studies support the inference that second generation cathinones pentylone and pentedrone have abuse liability greater than that of methylone.Keywords
All Related Versions
- Published version: Neuropharmacology, 134, 57.
This publication has 41 references indexed in Scilit:
- Online test purchased new psychoactive substances in 5 different European countries: A snapshot study of chemical composition and priceInternational Journal of Drug Policy, 2017
- The prevalence of new psychoactive substances in biological material – a three‐year review of casework in PolandDrug Testing and Analysis, 2015
- One day access to a running wheel reduces self-administration of d-methamphetamine, MDMA and methyloneDrug and Alcohol Dependence, 2015
- In vivo potency and efficacy of the novel cathinone α-pyrrolidinopentiophenone and 3,4-methylenedioxypyrovalerone: self-administration and locomotor stimulation in male ratsPsychopharmacology, 2015
- Intravenous self-administration of mephedrone, methylone and MDMA in female ratsNeuropharmacology, 2015
- A 3-year review of new psychoactive substances in caseworkForensic Science International, 2014
- Abuse-related and abuse-limiting effects of methcathinone and the synthetic “bath salts” cathinone analogs methylenedioxypyrovalerone (MDPV), methylone and mephedrone on intracranial self-stimulation in ratsPsychopharmacology, 2013
- The novel recreational drug 3,4-methylenedioxypyrovalerone (MDPV) is a potent psychomotor stimulant: Self-administration and locomotor activity in ratsNeuropharmacology, 2013
- Mephedrone (4-methylmethcathinone) supports intravenous self-administration in Sprague-Dawley and Wistar ratsAddiction Biology, 2013
- Enduring Deficits in Sustained Visual Attention during Withdrawal of Intravenous Methylenedioxymethamphetamine Self-Administration in Rats: Results from a Comparative Study with d-Amphetamine and MethamphetamineNeuropsychopharmacology, 2006